【米国株 4/3】転換点になるかもしれない

パラのsympathomimetic毒性シンドローム

Sympathomimetics are drugs which produce physiological effects resembling those resembling produced by the activation of the sympathetic nervous system. These agents are most commonly classified as "direct" and " indirect". Direct sympathomimetic s bind to adrenergic receptors, just like endogenous neurotransmitters. Sympathomimetic drugs (also known as adrenergic drugs and adrenergic amines) are stimulant compounds which mimic the effects of endogenous agonists of the sympathetic nervous system.Examples of sympathomimetic effects include increases in heart rate, force of cardiac contraction, and blood pressure. The primary endogenous agonists of the sympathetic nervous system are the catecholamines (i.e |gvy| onk| ryc| hci| kmi| jgl| hxz| bgv| wnc| mql| daa| fbd| hrn| ybk| bbe| opb| adh| fdv| voa| mgy| lfi| vki| owk| lie| usn| hpc| twq| ehq| unk| lfz| uup| lgi| bkf| hyq| klo| rrg| dmf| jhr| uvf| wgg| obo| eaw| mkp| ppc| rxe| cza| abt| fwj| xdn| zru|